Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Emerging agents like Tirzepatide, which activates both GLP-1 and GIP receptors, and Orforglipron, a nonpeptide oral GLP-1 agonist in phase 2 trials, further expand the therapeutic potential of this class (23)(24)
Taking resM on an empty stomach is unlikely to cause harm but may reduce the immediate blood sugar benefits
Our program is designed to accommodate individuals with various health conditions
GLP-1 medications are recommended for adults with T2DM who have not achieved their target blood sugar control with oral medications, like metformin, especially those who are overweight, obese, or have other chronic health conditions
US$ 23.63
US$ 20.85
US$ 21.91
